Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03932760
Other study ID # IRB_00113917
Secondary ID R01NR017620
Status Completed
Phase N/A
First received
Last updated
Start date May 1, 2020
Est. completion date March 1, 2023

Study information

Verified date May 2024
Source University of Utah
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of the project is to evaluate for the first time, the effectiveness of using a telehealth approach to reducing perinatal depressive symptoms in diverse groups of childbearing women; urban and rural-dwelling, and from Hispanic and predominantly North European Descent populations. Pregnant women connect for one hour weekly, for 8 weeks, using their own electronic device, from whatever location they choose (e.g. home), to attend videoconference groups facilitated by a mental health professional. The approach is cost effective and reduces barriers to access to mental health services, particularly for women living in rural, low-resource, and minority communities, and those without adequate transportation, financial resources, childcare, or work release time.


Description:

Perinatal depression (PD) affects 12-15% of women and contributes to adverse outcomes, e.g. preterm birth, low birth weight, and impaired cognitive development of the child. Screening optimizes the detection of PD, but does not reduce barriers to mental health services (MHS) encountered by women who screen positive. A known shortage of MHS across the nation is a significant barrier, particularly in low resource and rural settings. Telehealth is a promising approach to reducing barriers, but there is little research on the effectiveness of telehealth to reduce perinatal depressive symptoms (PDS). There is high potential for telehealth to deliver effective, lower cost MHS to childbearing women, particularly those in low resource settings. The proposed project is a randomized controlled trial among women with mild to moderate PDS. The project aims to evaluate; 1) the effectiveness of a group mental health videoconference intervention (VCI) to reduce PDS across pregnancy and postpartum, and (2) differences in PDS between diverse groups of childbearing women: rural and urban-dwelling, and Latina and predominantly North European Descent (NED) populations. The investigators hypothesize that women participating in the VCI will have significantly lower PDS across pregnancy and postpartum than women in an equivalent attention control (AC) group, and the results will differ between diverse groups. A total of 192 women will be enrolled; 48 in each study group. Participants are randomly assigned to study groups: VCI +standard of care, or AC + standard of care. Sessions are delivered via Utah Telehealth Network (UTN). Women in both groups attend weekly one-hour group sessions for 8 weeks using any electronic device (laptop, tablet, smart phone) from their own home. PDS is measured six times throughout enrollment--Time 1 = pre-intervention; T2 = immediately following week 9 of group intervention classes (post-intervention), T3= 2 months post-intervention; T4= 4 months post-intervention; T5 = 6 months post-intervention; T6 = 8 post-intervention. This study is the first to use a VCI to engage women in a facilitated group approach to reducing PDS, and to evaluate the impact among diverse groups. The approach is cost effective and reduces barriers to access to MHS, particularly for women living in low-resource, and minority communities, and those without adequate transportation, childcare, or work release time. The VCI can be replicated in any setting (e.g. rural or urban), and can be adapted to the needs of diverse communities. The study advances the field by establishing whether a group telehealth intervention reduces PDS, and whether this differs based on the population. If effective and implemented broadly, far fewer women and families would suffer the negative consequences of depression. The project is in line with NINR's high priority areas, including the use of technology to promote health, and a focus on self-management and symptom science.


Recruitment information / eligibility

Status Completed
Enrollment 99
Est. completion date March 1, 2023
Est. primary completion date March 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - women age 18 and older - have a viable pregnancy (any gestational age) or postpartum (up to 6 months) - have an Edinburgh Postpartum Depression Scale (EPDS) score between 9 and 20 - are English or Spanish speaking - are receiving clinical services at a collaborating prenatal or public health clinic associated with the U of Utah or Utah rural Health Districts Exclusion Criteria: - women who have an EPDS score less than 9 or greater than 20 - have a current diagnosis of a serious mental illness, such as psychosis, schizophrenia, bipolar disorder, severe depression, suicidal ideation, homicidal ideation - begun taking or changed dosage of any medications for a mental health condition within the previous 6 weeks

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
UPLIFT Program
UPLIFT is based on cognitive behavioral therapy and mindfulness-based practices. Participants meet by videoconference using any electronic device (laptop, tablet, smart phone) from their own home.
Attention Control Group
Program is based on standard prenatal, childbirth, infant feeding, and parenting education curriculum. Participants meet by videoconference using any electronic device (laptop, tablet, smart phone) from their own home.

Locations

Country Name City State
United States University of Utah Salt Lake City Utah

Sponsors (2)

Lead Sponsor Collaborator
University of Utah National Institute of Nursing Research (NINR)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Depressive Symptoms Over Time Self-completed: Edinburgh Postnatal Depression Scale measures depression symptoms during pregnancy and postpartum. The instrument will measure depressive symptoms at 6 time points during pregnancy and postpartum. The instrument is on a scale of 0-30, with 0 indicating no symptoms, and 30 indicating the highest severity of symptoms. Scores < 10 = no depressive symptoms; 10-15 = mild; 16-20 = moderate; > 20 = severe. Time 1 = pre-intervention (Baseline); T2 = immediately following week 9 of group intervention classes (Post), T3= 2 months post-intervention; T4= 4 months post-intervention; T5 = 6 months post-intervention; T6 = 8 post-intervention
Secondary Change in Anxiety Symptoms Over Time Self-completed: Generalized Anxiety Disorder - 7 Item scale measures symptoms of anxiety. The instrument will measures anxiety symptoms at 6 time points during pregnancy and postpartum. The instrument is on a scale of 0-21, with 0 indicating no symptoms, and 21 indicating the highest severity of symptoms. Scores of < 5 = no anxiety; 5-9 = mild; 10-14 = moderate; > 15 = severe. Time 1 = pre-intervention; T2 = immediately following week 9 of group intervention classes (post-intervention), T3= 2 months post-intervention; T4= 4 months post-intervention; T5 = 6 months post-intervention; T6 = 8 post-intervention
See also
  Status Clinical Trial Phase
Terminated NCT04594525 - Maternal Telemental Health Interventions in Response to Covid-19* N/A
Completed NCT04846504 - Accelerating Implementation of Mindful Mood Balance for Moms N/A
Not yet recruiting NCT05175755 - Genetic Risk Factors Predictive of the Occurrence of Maternally Diagnosed Perinatal Depression in Women N/A
Recruiting NCT05897619 - Feasibility and Acceptability of a Novel Cognitive Behavioral Skills Mobile App for Pregnant and Postpartum Individuals N/A
Enrolling by invitation NCT04517981 - Cohort Study on the Outcome and Influencing Factors of Perinatal Depression
Completed NCT04094870 - A Pilot Trial of Perinatal Depression Treatment in HIV Infected Women Phase 4
Completed NCT03291600 - Virtual Psychiatric Care for Perinatal Depression N/A
Completed NCT03938350 - Dialectical Behavior Therapy for Pregnant Women N/A
Active, not recruiting NCT04300894 - "Mamma Mia" for Perinatal Health and Wellness N/A
Recruiting NCT05595486 - Baby2Home (B2H) Mobile Health Application N/A
Completed NCT03336541 - Low-dose Ketamine and Postpartum Depression in Parturients With Prenatal Depression Phase 4
Active, not recruiting NCT05393479 - "Thinking Healthy Programme" for Perinatal Depression in Nepal N/A
Completed NCT05463926 - Effect of 'Parentbot - a Digital Healthcare Assistant (PDA)' in Improving Parenting Outcomes During the Perinatal Period N/A
Completed NCT05119062 - The Feasibility of an Online Intergenerational Co-parenting Program N/A
Enrolling by invitation NCT04838210 - Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care N/A
Not yet recruiting NCT06405932 - Study of the Intervention Effect of Self-help Training Camps in Promoting Mental Health Among Perinatal Women N/A
Not yet recruiting NCT06383221 - Study of the Intervention Effect of Stepped-care Models on Depression Symptoms During Pregnancy. N/A
Not yet recruiting NCT06364488 - TrueBlue Clinical Study - Investigating the Use of a Mobile Phone App TrueBlue for Monitoring Depression and Anxiety N/A
Active, not recruiting NCT05196152 - MomMoodBooster VA Program N/A
Completed NCT02935504 - PRogram In Support of Moms (PRISM): A Pilot Study N/A